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Outcomes of Open Repair of Mycotic Aortic Aneurysms 
with In Situ Replacement
Hyo-Hyun Kim, M.D., Do Jung Kim, M.D., Hyun-Chel Joo, M.D.
Department of Cardiovascular Surgery, Severance Cardiovascular Hospital, Yonsei University College of Medicine
Background: Mycotic aortic aneurysms are rare and life-threatening. Unfortunately, no established guidelines 
exist for the treatment of patients with mycotic aortic aneurysms. The purpose of this study was to evaluate 
the midterm outcomes of the open repair of mycotic thoracic and thoracoabdominal aneurysms and suggest 
a therapeutic strategy. Methods: From 2006 to 2016, 19 patients underwent open repair for an aortic 
aneurysm. All infected tissue was extensively debrided and covered with soft tissue. We recorded the clinical 
findings, anatomic location of the aneurysm, bacteriology results, antibiotic therapy, morbidity, and mortality 
for these cases. Results: The median age was 62±7.2 years (range, 16 to 78 years), 13 patients (68%) were 
men, and the mean aneurysm size was 44.5±4.9 mm. The mean time from onset of illness to surgery was 
14.5±2.4 days. Aortic continuity was restored in situ with a Dacron prosthesis (79%), homograft (16%), or 
Gore-Tex graft (5%). Soft-tissue coverage of the prosthesis was performed in 8 patients. The mean follow-up 
time was 43.2±11.7 months. The early mortality rate was 10.5%, and the 5-year survival rate was 
74.9%±11.5%. Conclusion: This study showed acceptable early and midterm outcomes of open repair of my-
cotic aneurysms. We emphasize that aggressive intraoperative debridement with soft-tissue coverage results 
in a high rate of success in these high-risk patients.
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Mycotic thoracic abdominal aortic aneurysms are 
rare, accounting for fewer than 1% of all aortic 
aneurysms. They are associated with a high incidence 
of fatal rupture when medical therapy alone is 
attempted. Although there are no standard guidelines 
for treatment, the most common practice is to com-
bine antibiotic therapy with surgical resection and 
graft interposition [1-3]. The purpose of this study 
was to assess the midterm outcomes of open repair 
of mycotic aortic aneurysms with soft-tissue coverage 
during a 10-year period at the Severance Hospital, 
Yonsei University College of Medicine.
Methods
From January 2006 to December 2016, 19 patients 
underwent open repair of a mycotic aortic aneurysm. 
We reviewed prospectively collected data to identify 
patients who underwent surgical repair for mycotic 
aortic aneurysms. This study was conducted follow-
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Chronic renal disease 4 (21)
Diabetes mellitus 6 (32)
Hypertension 5 (26)
Tumors 2 (11)
Symptoms and clinical findings
Pain 10 (53)
Fever 8 (42)
Hematochezia, hemoptysis 4 (21)
Extremities weakness 2 (11)
None 1 (5)
Location of mycotic aneurysm
Ascending aorta 3 (16)
Descending thoracic aorta 6 (32)
Thoracoabdominal aorta 2 (11)
Abdominal aorta 8 (42)
In-hospital mortality 2 (10.5)
Sepsis 1 (5.2)
Acute myocardial infarction 1 (5.2)
Morbidities
Stroke 0
Postoperative bleeding 1 (5.2)
Acute renal failure 1 (5.2)
Pulmonary complications 4 (21.1)
Length of stay in intensive care unit (day) 11±19.7
Length of hospital stay (day) 52±44.6
Reinfection 1 (5.2)
Values are presented as mean±standard deviation or number (%).
ing approval by the Institutional Review Board of the 
Yonsei University College of Medicine (IRB number: 
4_2011_0173). The individual patient consent was 
waived. Aneurysms were defined as mycotic if its 
characteristic appearance was observed in radiologic 
imaging or during an intraoperative examination, and 
if positive cultures were obtained from either blood 
or aortic tissue. Computed tomography (CT) imaging 
was used to determine whether the aneurysm was 
rapidly growing, had newly developed, and whether 
there was air in the aortic wall or a soft-tissue mass 
surrounding the aneurysmal aorta. The primary end-
points were in-hospital mortality and late death from 
any cause. The secondary endpoints were early ma-
jor complications and a composite of late aortic 
events.
1) Surgical technique
All procedures were performed with sternotomy, 
left thoracotomy, or left thoracoabdominal or median 
abdominal incision, depending on the anatomic loca-
tion of the aneurysm. Infected tissues were com-
pletely excised, and aortic continuity was restored 
with a Dacron prosthesis (Macquet Corp., Oakland, 
NJ, USA), homograft, or Gore-Tex (W. L. Gore & Asso-
ciates, Elkton, MD, USA) graft. Cryopreserved arterial 
homografts were used in infections that were not 
controlled by antibiotic therapy. Soft-tissue coverage 
of the prosthesis was performed when permitted by 
the anatomy and patient condition [1,4,5].
2) Statistics
Data processing and analysis were performed us-
ing IBM SPSS ver. 20.0 (IBM Corp., Armonk, NY, 
USA). Results are expressed as frequency and per-
centage for categorical variables and as mean and 
standard deviation for continuous variables. All p-val-
ues ＜0.05 were considered to indicate statistical 
significance. Survival estimates were generated using 
the Kaplan-Meier method.
Results
1) Patients and characteristics
Patient characteristics are listed in Table 1. The 
median age was 62±7.2 years (range, 16 to 78 
years). The series of 19 patients consisted of 13 men 
(68.4%) and 6 women (31.6%). Nine patients 
(47.4%) had at least 1 comorbid condition associated 
with some degree of immunosuppression, including 6 
(31.6%) with diabetes mellitus, 4 (21.0%) with 
chronic renal disease, or 2 (10.5%) with benign or 
malignant tumors.
2) Symptoms and clinical findings
In this study, 95% of patients presented with 
aneurysm-related symptoms: pain (n=10, 53%), fever 
(n=8, 42%), or hematochezia or hemoptysis (n=4, 
21%). Preoperative CT was performed in all patients; 
the mean aneurysm size was 44.5±4.9 mm. Six pa-
tients (31.5%) had a contained rupture at the time 
of surgery. The average duration of symptoms before 
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Fig. 1. Photographs taken intraoperatively showing replacement
with a Dacron graft (A) and homograft (B) with omental flaps (C).
surgery was 14.5±4.7 days.
3) Anatomic location
Of the 19 mycotic aneurysms, 3 (15.8%) were as-
cending, 6 (31.6%) were descending thoracic, 2 
(10.5%) were thoracoabdominal, and 8 (42.1%) were 
abdominal.
4) Surgical procedure
Following radical debridement of the infected tis-
sue, Dacron grafts (n=15, 78.9%) (Fig. 1A), cry-
opreserved arterial homografts (n=3, 15.8%) (Fig. 
1B), or a Gore-Tex graft (n=1, 5.3%) was placed in 
situ in the normal anatomic position. Nine patients 
(47.4%) had additional soft-tissue coverage, including 
8 (42.1%) with an omental flap (Fig. 1C) and 1 
(5.3%) with a pectoralis major muscle flap (Table 2).
5) Bacteriology and antibiotic treatment
Blood cultures were positive for Staphylococcus 
aureus in 4 patients (21%), while 3 (15.7%) had 
Enterobacter species. Nine (47%) had negative cul-
ture results. The remaining results of the bacterio-
logical analysis are outlined in Table 2. Patients were 
initially administered broad-spectrum antibiotics, fol-
lowed by targeted antibiotics after the causative or-
ganisms were identified and their susceptibility 
analyzed. Broad-spectrum intravenous antibiotics were 
administered in the early postoperative period for 4–6 
weeks and then replaced by oral therapy based on 
the results of the bacteriological analysis [6,7].
6) Short-term outcomes
The mean intensive care unit (ICU) stay and 
in-hospital stay were 11±19.7 and 52±44.6 days, 
respectively. There were 2 in-hospital deaths (10.5%), 
secondary to sepsis and acute myocardial infarction.
7) Long-term outcomes
The mean follow-up time of the patients was 
43.2±11.7 months. Two patients (10.5%) died of 
aneurysm-related complications during the follow-up 
period. One patient presented 32.4 months post-
operatively with massive hematemesis due to an aor-
to-enteric fistula. Another patient died 61.9 months 
postoperatively due to sepsis from a mediastinal ab-
scess resulting from graft reinfection (Table 1). 
During follow-up, 1 patient had a prosthetic graft re-
infection, as mentioned above. None of the patients 
had a spinal cord injury or stroke. One patient re-
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Fig. 2. Kaplan-Meier survival estimates of mycotic aortic aneurysms.
quired new-onset dialysis and developed permanent 
renal failure. None of the patients underwent 
reoperation. The 5-year survival rate after surgery 
was 74.9%±11.5% (Fig. 2).
Discussion
Mycotic aneurysms were first described by Osler 
in 1885, referring to infected aneurysms secondary 
to septic embolisms due to endocarditis. The in-
cidence of infected aneurysms is higher when in-
vasive monitoring techniques, angiography, and other 
percutaneous techniques are performed; it is also 
higher in patients with immunosuppressive con-
ditions and in intravenous drug users [8,9].
A European multicenter collaboration of 16 centers 
was conducted to retrospectively evaluate the dura-
bility of endovascular aortic repair in patients with 
mycotic aortic aneurysms, by assessing late in-
fection-related complications and long-term survival. 
In that study, 5% of patients were converted to open 
repair during a mean follow-up period of 35 months, 
and the 5-year survival rate was 55% [10]. In anoth-
er study, in-hospital mortality was 22.7% in the ex-
tra-anatomic reconstruction group and 18.9% in the 
in situ repair group [11]. Our hospital has consid-
erable experience with in situ repair; the in-hospital 
mortality rate was 10.5% and the 5-year survival 
rate was 74.9%±11.5% during the 43.2-month fol-
low-up period. In situ revascularization has gradually 
become a standard procedure, based on good results 
reported in the literature [11-13]. Therefore, the use 
of stent grafts in the setting of infection could be 
performed just as a bridge procedure to open repair, 
because the endograft inevitably becomes infected 
and fails.
The choice of the ideal conduit is still controversial 
[12]. To reduce the risk of reinfection, rifampicin-im-
pregnated grafts or cryopreserved arterial homografts 
can be used instead of prosthetic grafts. However, no 
studies have confirmed the superiority of rifampi-
cin-impregnated grafts. Cryopreserved arterial homo-
grafts have lower rates of reinfection (approximately 
20%) but higher rates of aneurysmal degeneration 
and rupture (0%–9%) [7,14,15]. Lau et al. [1] re-
ported that the 5-year survival rate of aortic surgical 
repair using Dacron prostheses was 71%, with no 
prosthetic graft infection observed during follow-up. 
This study also demonstrates that using Dacron pros-
thetic grafts led to acceptable outcomes in terms of 
reinfection and surgical outcomes.
To reduce the risk of reinfection, we covered the 
graft with a pedicle of uninfected tissue, such as the 
omentum; increased the blood supply; and increased 
the antibiotic concentration in the area [11]. In our 
series, we observed only 1 case of reinfection (5.2%) 
after in situ reconstruction. Our data show that fa-
vorable results can be obtained by in situ revascula-
rization, aggressive debridement, and soft-tissue cov-
erage in cases without an advanced-stage infection.
Although mycotic aneurysms have been reported 
in all age groups, the typical patient is elderly and 
has atherosclerosis [5,16,17]. In our study, the mean 
age of the patients was 62±7.2 years. Compared with 
noninfected aortic aneurysms, mycotic aneurysms 
tend to be symptomatic [18]. Almost all of our pa-
tients had aneurysm-related symptoms, including fe-
ver and pain (Tables 1, 2). Therefore, early operative 
intervention is indicated in these cases, especially for 
older patients with symptomatic aortic aneurysms.
In the literature, the most frequently reported mi-
croorganisms related to mycotic aneurysms are 
Staphylococcus, Streptococcus, and Gram-negative mi-
croorganisms, such as Klebsiella pneumoniae and 
Salmonella [5]. Gram-negative microorganisms are 
thought by many to exhibit a more virulent course, 
because of their ability to invade the normal intima 
and cause early aneurysm rupture [3]. In this study, 
the patient with Salmonella presented with a rupture 
at admission; she also had the longest ICU and hos-
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pital stay due to sepsis. Therefore, if a positive cul-
ture is found for Gram-negative microorganisms, ag-
gressive surgical treatment and antibiotic suppression 
therapy are needed to prevent a fatal outcome.
The outcome of surgery depends on several fac-
tors, including the type and location of the aneurysm, 
the form of presentation, the patient’s comorbidities, 
the microorganism that is isolated, the type and du-
ration of antibiotic therapy, and the type of surgery 
[11]. Our results suggest that uncontrolled fever, rup-
ture, and Gram-negative microorganisms are risk fac-
tors for adverse surgical outcomes.
In our series, because of the lack of power in the 
sample and the retrospective nature of the study, a 
robust statistical analysis was not possible. Therefore, 
a much greater number of cases than were available 
for this series is necessary to demonstrate any influ-
ence of the surgical technique on outcomes.
In conclusion, the early and midterm outcomes of 
the open repair of mycotic aneurysms were favorable. 
Aggressive intraoperative debridement with in situ 
prosthetic reconstruction and soft-tissue coverage 
yielded a high rate of success in these very high-risk 
patients.
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